Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SMAD family member 9 | 0.666 | 0.308 | 6.4E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
G protein-coupled receptor 182 | 0.691 | 0.462 | 1.4E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
5'-aminolevulinate synthase 1 | 0.705 | 0.462 | 0.11 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
potassium voltage-gated channel subfamily A member 5 | 0.606 | 0.500 | 1.1E-03 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2010 | 2017 | ||||||||
|
tachykinin receptor 2 | 0.700 | 0.500 | 8.8E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
ATP synthase peripheral stalk subunit F6 | 0.716 | 0.538 | 6.1E-03 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2016 | 2016 | ||||||||
|
hypoxia inducible factor 3 subunit alpha | 0.682 | 0.538 | 1.5E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
hyaluronan synthase 1 | 0.670 | 0.577 | 1.3E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
hyaluronidase 1 | 0.633 | 0.577 | 1.9E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
phosphodiesterase 3A | 0.670 | 0.577 | 1.9E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
mitofusin 1 | 0.644 | 0.577 | 2.5E-10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
hyaluronidase 2 | 0.644 | 0.577 | 0.19 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
sphingomyelin phosphodiesterase 3 | 0.659 | 0.615 | 0.59 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
caveolae associated protein 1 | 0.559 | 0.654 | 5.0E-03 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2012 | 2013 | ||||||||
|
prostaglandin I2 synthase | 0.617 | 0.654 | 1.2E-09 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 1999 | 2004 | ||||||||
|
receptor activity modifying protein 2 | 0.626 | 0.654 | 5.1E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
epoxide hydrolase 2 | 0.568 | 0.654 | 1.8E-21 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
hyaluronan synthase 2 | 0.588 | 0.692 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
hyaluronan synthase 3 | 0.644 | 0.692 | 0.88 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
inhibitor of DNA binding 1, HLH protein | 0.544 | 0.692 | 3.1E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
SMAD family member 1 | 0.533 | 0.731 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 2 | 0 | 2007 | 2008 | ||||||||
|
collagen type IV alpha 1 chain | 0.484 | 0.731 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
endothelial PAS domain protein 1 | 0.454 | 0.731 | 0.60 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
arachidonate 5-lipoxygenase activating protein | 0.612 | 0.731 | 7.1E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 |